Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma

Journal of Nuclear Medicine

Volumn 42, Issue 4, 2001, Pages 601-608

  Tatsumi, M ^a   Kitayama, H ^a   Sugahara, H ^a   Tokita, N ^a   Nakamura, H ^a   Kanakura, Y ^a   Nishimura, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CT; Dedicated PET; FDG; Hybrid PET; Non Hodgkin's lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GALLIUM CITRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTILLATION CAMERA; TUMOR DIAGNOSIS; WHOLE BODY SCANNER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; GAMMA CAMERAS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035051380     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The National Cancer Data Base report on non-Hodgkin's lymphoma
2. Cancer incidence and mortality, 1973-1995: A report card for the U.S.
3. Computed tomography, lymphography, and staging laparotomy: Correlations in initial staging of Hodgkin disease
4. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma
5. Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma and melanoma
6. The role of FDG PET in the clinical management of head and neck cancer
7. PET in lung cancer
8. Oncological applications of FDG PET imaging
9. A fluorinated glucose analog. 2-fluoro-2-deoxy-D glucose (F-18): Nontoxic tracer for rapid tumor detection
10. Positron imaging feasibility studies. II. Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: Concise communication
11. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma
12. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis
13. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT
14. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma
15. Lymphoma: Role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
16. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: Effectiveness and comparison with computed tomography
17. Coincidence imaging with a dual-head scintillation camera
18. PET imaging using dual-headed gamma cameras: An update
19. Oncologic diagnosis with 2-[fluorine-18] fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner
20. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(TI) crystals in patients with suspected body malignancies
21. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: A pilot study
22. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis
23. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: Comparison with FDG PET
24. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
25. Lymphoma classification: The gap between biology and clinical management is closing
26. Upper abdominal lymph nodes: Criteria for normal size determined with CT
27. Abdominal lymphadenopathy: Spectrum of CT findings
28. Current role of gallium scanning in the management of lymphoma
29. SPECT scanner with PET coincidence capability
30. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: A study with positron emission tomography and fluorine-18-fluorodeoxyglucose
31. FDG imaging of lung nodules: A phantom study comparing SPECT, camera-based PET, and dedicated PET
32. Extranodal malignant lymphoma: Detection with FDG PET versus CT
33. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study
34. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity